Search results
Author(s):
Barbara McGowan
Added:
11 months ago
ECO 2024 — Prof Barbara McGowan (Guy's and St Thomas' Hospital & King's College, UK) joins us to discuss the findings from the STEP 10 trial (NCT05040971, Novo Nordisk).This Phase 3 randomised clinical trial investigated the efficacy and safety of subcutaneous semaglutide 2.4 mg (GLP-1 RA) in 181 participants with obesity (BMI greater than or equal to 30.0 kg/m^2) and prediabetes. The primary…
View more
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
2 months ago
Author(s):
Carlos Millán-Rodríguez
,
Carlos Palacios Castelló
,
María de Regla Caballero-Valderrama
,
et al
Added:
1 year ago
Author(s):
Sheila Gato
,
Vanessa García-Fernández
,
Antonio Gil-Gómez
,
et al
Added:
1 year ago